Chris Cano, Chief Executive Officer

Christopher Cano is the Chief Executive Officer of Cellergy Pharma. Mr. Cano is a seasoned pharmaceutical/biotech executive bringing more than 20 years of global operational and business development expertise to Cellergy Pharma. 

Drawing from transactional experiences spanning the breadth of life science verticals, Mr. Cano’s specialty is building and growing early-stage companies from seed funding through public offerings, with an emphasis on partnering, licensing, and M&A transactions with strategic collaborators.

Prior to joining Cellergy Pharma, Mr. Cano was the Chief Operating Officer and VP of Business Development at TFF Pharmaceuticals. Mr. Cano is also the managing director of a BD&L consulting company, C2 Strategic Solutions, which has provided BD&L services to clients in the biotechnology, pharma and drug delivery industry.

Mr. Cano is based out of Princeton, NJ and holds a bachelor’s degree in finance from Villanova University and a master’s degree in business management from Rider University.